FDA commissioner warns drug companies of 'disruptive' regulations to fight opioid epidemic

The FDA could take actions on opioids that are "disruptive" and "uncomfortable" to drugmakers, FDA Commissioner Scott Gottlieb says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.